Cancer Care Ontario | Cancer Care Ontario

405 Results

Guidelines and Advice

Systemic Treatment Emergency Preparedness Guidance Document

Status: Current

Updated

Aug 2025

Guidelines and Advice

Safe Handling of Hazardous Drugs

Status: Current
ID: GL 16-3
Version: 3

Mar 2022

Drug

irinotecan

Other Name(s): Camptosar®

Quick Link(s): Drug Monograph, Patient Info Sheet

Sep 2025

Drug

iBRUtinib

Other Name(s): Imbruvica®

Quick Link(s): Drug Monograph, Patient Info Sheet

Sep 2025

Guidelines and Advice

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Status: Current
ID: 7-13
Version: 2

Updated

Sep 2025

Guidelines and Advice

Surveillance of Patients with Stage I, II, III, or Resectable IV Melanoma Who Were Treated with Curative Intent

Status: Current
ID: 8-7
Version: 2

Mar 2023

Drug

ivosidenib

Other Name(s): Tibsovo®

Quick Link(s): Drug Monograph, Patient Info Sheet

Updated

Oct 2025

Guidelines and Advice

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Status: Current
ID: 7-A-2022-1-17v3
Version: 3

Oct 2023

Systemic Treatment Emergency Preparedness Guidance Document

Safe Handling of Hazardous Drugs

irinotecan

iBRUtinib

Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy

Surveillance of Patients with Stage I, II, III, or Resectable IV Melanoma Who Were Treated with Curative Intent

ivosidenib

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Smoking Cessation Information for Healthcare Providers

Pages